Prior to founding ImmBio, Dr Colaço was Director of Intellectual Property (IP) for the biotechnology company Quadrant Healthcare plc, where he was responsible for development of the IP portfolio that formed the basis of its successful listing on the London Stock Exchange and acquisition by Elan. Dr Colaço was responsible for generating the IP that formed their biomolecule stabilisation and delivery technology. In addition to his industry experience, Dr Colaço has worked in a number of leading instituations, including the University of Cambridge Medical School. He has a degree in Biochemistry from the University of London and PhD from the National Institute of Medical Research, London.
EVEN MORE SEMINARS
Professor A. Graham Pockley multimmune GmbH / Nottingham Trent University
A new era of cancer therapeutics?
Rob Duncombe The Christie NHS Foundation Trust
Medicine Optimisation in Oncology. How to achieve best value.
Hazel Pennington Lead Radiographer Proton Therapy Project at The Christie NHS Foundation Trust
Chris Curtis The Swallows Head & Neck Cancer Charity
A patient’s journey ‘Cancer to the palace in 6yrs’
Professor Alex Mirnezami University of Southampton
Biomarkers of Epithelial to Mesenchymal Transition and their clinical relevance in colorectal cancer